Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 361

1.

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.

Seligmann JF, Hatch AJ, Richman SD, Elliott F, Jacobs B, Brown S, Hurwitz H, Barrett JH, Quirke P, Nixon AB, Seymour MT.

JAMA Oncol. 2017 Oct 26. doi: 10.1001/jamaoncol.2017.3168. [Epub ahead of print]

PMID:
29075780
2.

Internal anal sphincter nerves - a macroanatomical and microscopic description of the extrinsic autonomic nerve supply of the internal anal sphincter.

Stelzner S, Böttner M, Kupsch J, Kneist W, Quirke P, West NP, Witzigmann H, Wedel T.

Colorectal Dis. 2017 Oct 25. doi: 10.1111/codi.13942. [Epub ahead of print]

PMID:
29068554
3.

Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial.

Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J.

JAMA. 2017 Oct 24;318(16):1569-1580. doi: 10.1001/jama.2017.7219.

PMID:
29067426
4.

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.

Bosch LJW, Trooskens G, Snaebjornsson P, Coupé VMH, Mongera S, Haan JC, Richman SD, Koopman M, Tol J, de Meyer T, Louwagie J, Dehaspe L, van Grieken NCT, Ylstra B, Verheul HMW, van Engeland M, Nagtegaal ID, Herman JG, Quirke P, Seymour MT, Punt CJA, van Criekinge W, Carvalho B, Meijer GA.

Oncotarget. 2017 Jun 27;8(38):63140-63154. doi: 10.18632/oncotarget.18702. eCollection 2017 Sep 8.

5.

A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota.

Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, Dye L, Loadman PM, Hull MA.

Gut. 2017 Sep 26. pii: gutjnl-2017-314968. doi: 10.1136/gutjnl-2017-314968. [Epub ahead of print]

PMID:
28951525
6.

Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.

Gollins S, West N, Sebag-Montefiore D, Myint AS, Saunders M, Susnerwala S, Quirke P, Essapen S, Samuel L, Sizer B, Worlding J, Southward K, Hemmings G, Tinkler-Hundal E, Taylor M, Bottomley D, Chambers P, Lawrie E, Lopes A, Beare S.

Br J Cancer. 2017 Oct 24;117(9):1286-1294. doi: 10.1038/bjc.2017.294. Epub 2017 Aug 31.

7.

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Battersby NJ, Dattani M, Rao S, Cunningham D, Tait D, Adams R, Moran BJ, Khakoo S, Tekkis P, Rasheed S, Mirnezami A, Quirke P, West NP, Nagtegaal I, Chong I, Sadanandam A, Valeri N, Thomas K, Frost M, Brown G.

Trials. 2017 Aug 29;18(1):394. doi: 10.1186/s13063-017-2085-2.

8.

The Effect of a Multidisciplinary Regional Educational Programme on the Quality of Colon Cancer Resection.

Sheehan-Dare GE, Marks KM, Tinkler-Hundal E, Ingeholm P, Bertelsen CA, Quirke P, West NP.

Colorectal Dis. 2017 Jul 29. doi: 10.1111/codi.13830. [Epub ahead of print]

PMID:
28755446
9.

Intratumoral stromal morphometry predicts disease recurrence but not response to 5-fluorouracil-results from the QUASAR trial of colorectal cancer.

Hutchins GGA, Treanor D, Wright A, Handley K, Magill L, Tinkler-Hundal E, Southward K, Seymour M, Kerr D, Gray R, Quirke P; QUASAR trial collaborators and the UK National Cancer Research Institute Colorectal Cancer Clinical Studies Group.

Histopathology. 2017 Jul 26. doi: 10.1111/his.13326. [Epub ahead of print]

PMID:
28746977
10.

Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Pathology Standards and Datasets.

Langman G, Loughrey M, Shepherd N, Quirke P.

Colorectal Dis. 2017 Jul;19 Suppl 1:74-81. doi: 10.1111/codi.13708. No abstract available.

PMID:
28632310
11.

Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, Fléjou JF, Hansen TP, Hartmann A, Kakar S, Langner C, Nagtegaal I, Puppa G, Riddell R, Ristimäki A, Sheahan K, Smyrk T, Sugihara K, Terris B, Ueno H, Vieth M, Zlobec I, Quirke P.

Mod Pathol. 2017 Sep;30(9):1299-1311. doi: 10.1038/modpathol.2017.46. Epub 2017 May 26.

PMID:
28548122
12.

Urgent improvements needed to diagnose and manage Lynch syndrome.

Monahan KJ, Alsina D, Bach S, Buchanan J, Burn J, Clark S, Dawson P, De Souza B, Din FV, Dolwani S, Dunlop MG, East J, Evans DG, Fearnhead N, Frayling IM, Glynne-Jones R, Hill J, Houlston R, Hull M, Lalloo F, Latchford A, Lishman S, Quirke P, Rees C, Rutter M, Sasieni P, Senapati A, Speake D, Thomas H, Tomlinson I.

BMJ. 2017 Mar 20;356:j1388. doi: 10.1136/bmj.j1388. No abstract available.

PMID:
28320700
13.

Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing.

Wood HM, Foster JM, Taylor M, Tinkler-Hundal E, Togneri FS, Wojtowicz P, Oumie A, Spink KG, Brew F, Quirke P.

BMC Med Genomics. 2017 Mar 18;10(1):17. doi: 10.1186/s12920-017-0254-5.

14.

Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.

Nagtegaal ID, Knijn N, Hugen N, Marshall HC, Sugihara K, Tot T, Ueno H, Quirke P.

J Clin Oncol. 2017 Apr 1;35(10):1119-1127. doi: 10.1200/JCO.2016.68.9091. Epub 2016 Dec 28. Review.

PMID:
28029327
15.

Examining the potential use and long-term stability of guaiac faecal occult blood test cards for microbial DNA 16S rRNA sequencing.

Taylor M, Wood HM, Halloran SP, Quirke P.

J Clin Pathol. 2017 Jul;70(7):600-606. doi: 10.1136/jclinpath-2016-204165. Epub 2016 Dec 23.

PMID:
28011577
16.

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials.

Seligmann JF, Fisher D, Smith CG, Richman SD, Elliott F, Brown S, Adams R, Maughan T, Quirke P, Cheadle J, Seymour M, Middleton G.

Ann Oncol. 2017 Mar 1;28(3):562-568. doi: 10.1093/annonc/mdw645.

PMID:
27993800
17.

A retrospective observational study of length of stay in hospital after colorectal cancer surgery in England (1998-2010).

Aravani A, Samy EF, Thomas JD, Quirke P, Morris EJ, Finan PJ.

Medicine (Baltimore). 2016 Nov;95(47):e5064.

18.

Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR).

Harris DA, Thorne K, Hutchings H, Islam S, Holland G, Hatcher O, Gwynne S, Jenkins I, Coyne P, Duff M, Feldman M, Winter DC, Gollins S, Quirke P, West N, Brown G, Fitzsimmons D, Brown A, Beynon J.

BMJ Open. 2016 Nov 21;6(11):e012496. doi: 10.1136/bmjopen-2016-012496.

19.

Challenging diagnostic issues in adenomatous polyps with epithelial misplacement in bowel cancer screening: 5 years' experience of the Bowel Cancer Screening Programme Expert Board.

Griggs RK, Novelli MR, Sanders DS, Warren BF, Williams GT, Quirke P, Shepherd NA.

Histopathology. 2017 Feb;70(3):466-472. doi: 10.1111/his.13092. Epub 2016 Nov 15.

PMID:
27676454
20.

Significant Individual Variation Between Pathologists in the Evaluation of Colon Cancer Specimens After Complete Mesocolic Excision.

Munkedal DL, Laurberg S, Hagemann-Madsen R, Stribolt KJ, Krag SR, Quirke P, West NP.

Dis Colon Rectum. 2016 Oct;59(10):953-61. doi: 10.1097/DCR.0000000000000671.

PMID:
27602926

Supplemental Content

Loading ...
Support Center